{
  "first_published_at": "2010-10-11", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON096800", 
  "title": "Mercaptamine and mercaptopurine: confusion between drug names", 
  "tags": "{\"parsed_therapeutic\": [\"urology-nephrology\", \"cancer\", \"haematology\"], \"Audience:\": [\"Primary care\", \"Secondary care\"], \"Therapeutic area:\": [\"Urology and nephrology\", \"Cancer\", \"Haematology\"]}", 
  "_document_number": 183, 
  "label": "Reminder", 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/dose_icon.png", 
  "therapeutic_area": [
    "urology-nephrology", 
    "cancer", 
    "haematology"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Mercaptamine and mercaptopurine: confusion between drug names</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: October 2010</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!--We would like to remind prescribers to remain vigilant with regards to the similarity of these two drug names-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<div id=\"dsuSynopsis\" class=\"yellow\">\r\n\t\t\t\t\t\t\t\t\t<div class=\"dsuArticlePadding\">\r\n\t\t\t\t\t\t\t\t\t<span id=\"dsuSynopsisTitle\"><b>Summary</b></span>\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<br>We would like to remind prescribers to remain vigilant with regards to the similarity of these two drug names<br>\t\r\n\t\t\t\t\t\t\t\t\t</div>         \t\t\r\n\t\t\t\t\t\t\t\t\t<div id=\"dsuSynopsisCut\">\r\n\t\t\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>We have been made aware of a medication error in which a 9-month-old who should have been prescribed mercaptamine by their GP was erroneously prescribed mercaptopurine. After about 1 month of incorrect therapy, the child was admitted to hospital with pancytopenia; the child has now made a full recovery.</p><p>We would like to remind prescribers to remain vigilant with regards to the similarity of these two drug names.</p><p>Mercaptamine is indicated for the treatment of proven nephropathic cystinosis. Mercaptopurine is indicated for the treatment of acute leukaemia.</p><p>Suspected adverse drug reactions, including those arising from medication errors, should be reported on a Yellow Card (see <a href=\"http://www.yellowcard.gov.uk\">www.yellowcard.gov.uk</a>).</p><p>&nbsp;</p><p><em>Article citation: Drug Safety Update October 2010: vol 4, issue 3: S3.</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>We have been made aware of a medication error in which a 9-month-old who should have been prescribed mercaptamine by their GP was erroneously prescribed mercaptopurine. After about 1 month of incorrect therapy, the child was admitted to hospital with pancytopenia; the child has now made a full recovery.</p><p>We would like to remind prescribers to remain vigilant with regards to the similarity of these two drug names.</p><p>Mercaptamine is indicated for the treatment of proven nephropathic cystinosis. Mercaptopurine is indicated for the treatment of acute leukaemia.</p><p>Suspected adverse drug reactions, including those arising from medication errors, should be reported on a Yellow Card (see <a href=\"http://www.yellowcard.gov.uk\">www.yellowcard.gov.uk</a>).</p><p>&#160;</p><p><em>Article citation: Drug Safety Update October 2010: vol 4, issue 3: S3.</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2010-10-01", 
  "date_last_modified": "2010-11-10", 
  "_assets": [], 
  "_item_id": 183, 
  "summary": "We would like to remind prescribers to remain vigilant with regards to the similarity of these two drug names", 
  "body": "Article date: October 2010\n\nWe have been made aware of a medication error in which a 9-month-old who should have been prescribed mercaptamine by their GP was erroneously prescribed mercaptopurine. After about 1 month of incorrect therapy, the child was admitted to hospital with pancytopenia; the child has now made a full recovery.\n\nWe would like to remind prescribers to remain vigilant with regards to the similarity of these two drug names.\n\nMercaptamine is indicated for the treatment of proven nephropathic cystinosis. Mercaptopurine is indicated for the treatment of acute leukaemia.\n\nSuspected adverse drug reactions, including those arising from medication errors, should be reported on a Yellow Card (see [www.yellowcard.gov.uk](http://www.yellowcard.gov.uk)).\n\nÂ \n\nArticle citation: Drug Safety Update October 2010: vol 4, issue 3: S3.\n"
}